Dr. Diana Bolotin is the Allan L. Lorincz Professor at the University of Chicago where she serves as the Chief of Dermatology, and the Director of Dermatologic Surgery and Dermatology Ambulatory Practice. She is actively engaged in patient care in surgical and cosmetic dermatology, resident teaching and investigator initiated as well as sponsored clinical research on cutaneous malignancies. Dr. Bolotin is a graduate of University of California, Berkeley (A.B. with Honors) and University of Chicago, Pritzker School of Medicine Medical Scientist Training Program (M.D., Ph.D.). She subsequently completed her Dermatology residency training at the University of Chicago, where she served as chief resident, followed by a Micrographic Surgery and Dermatologic Oncology/Procedural Dermatology fellowship at Northwestern University, Feinberg School of Medicine before returning as faculty to the University of Chicago. Dr. Bolotin is double board-certified in Dermatology and Micrographic Dermatologic Surgery. In her clinical work, she provides the full range of medical and surgical treatment for skin cancer and specializes in Mohs Micrographic Surgery (MMS), an advanced technique for the removal of certain types of skin cancer. Additionally, she is an expert in laser and aesthetic procedures and treatments. Dr. Bolotin is the author of multiple peer-reviewed journal articles and textbook chapters in her field and has been honored with several notable awards for her clinical work and research contributions. She is a member of the Editorial Boards of the Journal of the American Academy of Dermatology and Dermatologic Surgery Journal and an Associate Editor for Archives of Dermatologic Research. Outside of clinical work, education and research, Dr. Bolotin is active within Dermatology specialty societies including leadership roles within the American Society for Dermatologic Surgery, Association of Academic Cosmetic Dermatologists, American College of Mohs Surgery, Chicago Dermatologic Society and Illinois Dermatologic Society.
Barriers to clinical cosmetic and laser dermatology research in the academic setting by source of funding: a systematic review.
Barriers to clinical cosmetic and laser dermatology research in the academic setting by source of funding: a systematic review. Arch Dermatol Res. 2025 May 31; 317(1):791.
PMID: 40448830
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 Jan; 23(1).
PMID: 39819674
How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site identification is initially uncertain: A nationwide, multicenter, prospective study.
How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site identification is initially uncertain: A nationwide, multicenter, prospective study. J Am Acad Dermatol. 2025 Jan; 92(1):85-91.
PMID: 39307352
Strategies for overcoming obstacles to hands-on cosmetic and laser training in dermatology residency.
Strategies for overcoming obstacles to hands-on cosmetic and laser training in dermatology residency. J Am Acad Dermatol. 2025 Jan; 92(1):137-139.
PMID: 39284366
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study.
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study. J Natl Compr Canc Netw. 2024 07 30; 22(8).
PMID: 39079545
Availability of lasers and hands-on training in cosmetic dermatology in residency.
Availability of lasers and hands-on training in cosmetic dermatology in residency. J Am Acad Dermatol. 2024 Nov; 91(5):951-954.
PMID: 38972481
Recurrent Postoperative Hemorrhage After Mohs Reconstruction in a Patient on Ruxolitinib.
Recurrent Postoperative Hemorrhage After Mohs Reconstruction in a Patient on Ruxolitinib. OTO Open. 2024 Apr-Jun; 8(2):e133.
PMID: 38618287
Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study.
Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study. J Am Acad Dermatol. 2024 Jun; 90(6):1243-1245.
PMID: 38296200
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024. J Natl Compr Canc Netw. 2024 01; 22(1D):e240002.
PMID: 38244274
Concordance of basal cell carcinoma subtyping at biopsy vs. excision, and the implications for clinical approach: a multicenter cohort study.
Concordance of basal cell carcinoma subtyping at biopsy vs. excision, and the implications for clinical approach: a multicenter cohort study. Arch Dermatol Res. 2023 Dec 07; 316(1):23.
PMID: 38059991